American National Bank acquired a new stake in CME Group Inc (NASDAQ:CME) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,338 shares of the financial services provider’s stock, valued at approximately $220,000.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CI Investments Inc. increased its stake in shares of CME Group by 17.6% in the 3rd quarter. CI Investments Inc. now owns 336,170 shares of the financial services provider’s stock worth $57,219,000 after acquiring an additional 50,392 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of CME Group by 36.7% in the 3rd quarter. Franklin Resources Inc. now owns 2,086 shares of the financial services provider’s stock worth $355,000 after acquiring an additional 560 shares during the last quarter. LPL Financial LLC increased its stake in shares of CME Group by 9.2% in the 3rd quarter. LPL Financial LLC now owns 22,500 shares of the financial services provider’s stock worth $3,830,000 after acquiring an additional 1,897 shares during the last quarter. Vident Investment Advisory LLC increased its stake in shares of CME Group by 11.4% in the 3rd quarter. Vident Investment Advisory LLC now owns 5,709 shares of the financial services provider’s stock worth $972,000 after acquiring an additional 584 shares during the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in shares of CME Group by 2.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 14,621 shares of the financial services provider’s stock worth $2,489,000 after acquiring an additional 323 shares during the last quarter. 84.85% of the stock is owned by hedge funds and other institutional investors.
Shares of CME Group stock opened at $172.92 on Monday. CME Group Inc has a 12 month low of $153.90 and a 12 month high of $197.08. The stock has a market cap of $61.02 billion, a P/E ratio of 25.35, a PEG ratio of 3.48 and a beta of 0.29. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.01 and a quick ratio of 1.01.
CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.02. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same period last year, the business posted $1.12 EPS. CME Group’s revenue for the quarter was up 37.4% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc will post 6.82 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Monday, March 25th. Investors of record on Friday, March 8th were issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.73%. This is a boost from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date was Thursday, March 7th. CME Group’s dividend payout ratio (DPR) is 43.99%.
A number of analysts recently issued reports on the company. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, April 9th. Bank of America set a $180.00 price objective on CME Group and gave the stock a “hold” rating in a research report on Tuesday, April 9th. ValuEngine downgraded CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 20th. BidaskClub downgraded CME Group from a “sell” rating to a “strong sell” rating in a research report on Friday, March 22nd. Finally, Citigroup set a $205.00 price objective on CME Group and gave the stock a “buy” rating in a research report on Friday, February 15th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $192.00.
In other news, Director Ronald A. Pankau sold 200 shares of CME Group stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $182.90, for a total value of $36,580.00. Following the completion of the transaction, the director now owns 3,600 shares in the company, valued at approximately $658,440. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Kathleen M. Cronin sold 8,340 shares of CME Group stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $167.54, for a total value of $1,397,283.60. Following the completion of the transaction, the insider now owns 41,604 shares of the company’s stock, valued at approximately $6,970,334.16. The disclosure for this sale can be found here. Insiders have sold a total of 28,489 shares of company stock valued at $4,948,996 over the last 90 days. 1.20% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: This report was originally published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.thelincolnianonline.com/2019/04/15/american-national-bank-acquires-new-position-in-cme-group-inc-cme.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Further Reading: How Does the Quiet Period Work?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.